NRx is a clinical biopharma company focused on the high unmet need for lifesaving treatments for people with severe bipolar depression and PTSD in the presence of suicidality.

Get the latest NRx Pharmaceuticals, Inc. (NRXP) stock news and headlines to help you in your trading and investing decisions.

5 days ago · NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system …

May 15, 2025 · NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system …

Dec 26, 2025 · NRx Pharmaceuticals, Inc., a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising …

Get the latest NRX Pharmaceuticals Inc (NRXP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Nov 8, 2025 · NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment …

3 days ago · NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the six research firms that are covering …

Ascendiant raised the firm’s price target on NRx Pharmaceuticals (NRXP) to $48 from $47 and keeps a Buy rating on the shares following the Q3 report in November. The firm sees “major ...

We are NRx – a pioneering and focused CNS biopharma company, dedicated to meeting unmet medical needs for those with suicidal depression, suicidal bipolar depression, and post …